We bring together news, announcements and other updates from around Global Fund in this section. You can receive a notification every time a new update is published by using our really simple syndication (RSS) feed. See our RSS Feeds page for more information.
-
The following products have been recommended for use by the Expert Review Panel (ERP): Rifapentine 300mg tablets Al/Al strip pack manufactured by Lupin, India; Rifapentine/Isoniazid 300/300mg Al/Al strip pack manufactured by Lupin, India
-
-
03 May 2022
Global Fund Appoints Susie Rhee as General Counsel and Head of the Legal & Governance Department
The Global Fund is pleased to announce the appointment of Susie Rhee as the new General Counsel and Head of the Legal & Governance Department. -
29 April 2022Conflicts, Crises and Displaced People: How the Global Fund Works in Challenging Operating Environments - Thematic Report
-
08 April 2022
Opportunity for Evaluation of Diagnostic Products
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD). This evaluation will focus particularly on dia... -
-
-
-
The International Monetary Fund, in partnership with the Coalition for Epidemic Preparedness Innovations (CEPI), the Global Fund, and Wellcome Trust, is hosting a virtual press briefing for the publication of the “Building Resilience to Long-term Cov...
-
30 March 2022
Audit of the COVID-19 Response Mechanism 2021
The Global Fund’s COVID-19 Response Mechanism 2021 (C19RM 2021) has allowed countries to access significant amounts of financial support in a relatively short period of time, at a time when countries face critical funding gaps.